Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

BACKGROUND: Protection against herpes zoster (HZ) induced by the live attenuated zoster vaccine Zostavax (ZVL) wanes within 3–7 years. Revaccination may renew protection. We assessed whether (re)vaccination with the adjuvanted HZ subunit vaccine candidate (HZ/su) induced comparable immune responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C, Klein, Nicola P, Lal, Himal, Peterson, James, Vastiau, Ilse, Oostvogels, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853346/
https://www.ncbi.nlm.nih.gov/pubmed/29029122
http://dx.doi.org/10.1093/infdis/jix482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853346/
https://www.ncbi.nlm.nih.gov/pubmed/29029122
http://dx.doi.org/10.1093/infdis/jix482

Ejemplares similares